Ehlers-Danlos Syndrome

A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.

Also Known As:

Syndrome, Ehlers-Danlos; Ehlers Danlos Disease; Ehlers-Danlos Disease; Danlos Disease, Ehlers; Disease, Ehlers Danlos; Disease, Ehlers-Danlos; Ehlers Danlos Syndrome; Cutis Elastica

Cardiovascular Diseases: 94258
- Vascular Diseases: 15340
  - Hemostatic Disorders: 256
    - Ehlers-Danlos Syndrome: 812
Hemic and Lymphatic Diseases: 7
- Hematologic Diseases: 3445
  - Hemorrhagic Disorders: 706
    - Hemostatic Disorders: 256
      - Ehlers-Danlos Syndrome: 812
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 960
- Congenital Abnormalities: 26404
  - Skin Abnormalities: 159
    - Ehlers-Danlos Syndrome: 812
- Inborn Genetic Diseases: 12342
  - Genetic Skin Diseases: 51
    - Ehlers-Danlos Syndrome: 812
Skin and Connective Tissue Diseases
- Skin Diseases: 13402
  - Skin Abnormalities: 159
    - Ehlers-Danlos Syndrome: 812
  - Genetic Skin Diseases: 51
    - Ehlers-Danlos Syndrome: 812
- Connective Tissue Diseases: 3325
  - Collagen Diseases: 755
    - Ehlers-Danlos Syndrome: 812

Holly A Clayton Selected Research

Holly A Clayton Research Topics

Disease

Drug/Important Bio-Agent (IBA)